Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs) EQUITY
$53.87
pos +0.00
+0.00%
Today's Range: 52.09 - 56.71 | ENDP Avg Daily Volume: 3,700,800
Last Update: 02/05/16 - 3:59 PM EST
Volume: 0
YTD Performance: -11.99%
Open: $0.00
Previous Close: $54.30
52 Week Range: $46.66 - $96.58
Oustanding Shares: 226,449,346
Market Cap: 12,296,199,488
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 8
Moderate Buy 0 0 0 0
Hold 6 5 4 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.92 1.77 1.67 1.77
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -11.86
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-11.86 0.00 30.32
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.22% -32.09% 74.54%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.90 0.05 0.02
Net Income 0.00 -3.99 0.00
EPS 0.00 -4.05 0.00
Earnings for ENDP:
EBITDA 0.89B
Revenue 2.88B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $1.26 $1.31 $4.58 $5.95
Number of Analysts 9 4 4 13
High Estimate $1.34 $1.33 $4.60 $6.19
Low Estimate $1.11 $1.29 $4.55 $5.60
Prior Year $1.16 $1.17 $4.31 $4.58
Growth Rate (Year over Year) 8.81% 11.97% 6.15% 29.99%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Jan 7, 2016 | 12:00 PM EST

Mylan and Endo International look like bargains at current prices.

By

Bret Jensen

 | Dec 24, 2015 | 1:00 PM EST

These biotech/pharma picks could give you a very happy new year.

By

Bret Jensen

 | Nov 20, 2015 | 9:00 AM EST

The company cleared an important hurdle last month.

bearishEndo cut from Conviction Buy List at Goldman

Oct 26, 2015 | 7:40 AM EDT

ENDP was removed from the Conviction Buy list, according to Goldman Sachs. $84 price target. Company is leveraged to sector headwinds. 

bearishEndo downgraded at Morgan Stanley

Sep 1, 2015 | 6:43 AM EDT

ENDP was downgraded from Overweight to Equal-weight, Morgan Stanley said. $85 price target. Company has limited long-term growth visibility. 

bullishEndo upgraded at RBC

Jul 17, 2015 | 7:11 AM EDT

ENDP was upgraded from Outperform to Top Pick, RBC Capital said. $107 price target. Company is attractively valued and consensus numbers appear too low. 

By

Jim Cramer

 | May 18, 2015 | 3:24 PM EDT

Acquisitions cut into overabundance of companies.

By

Timothy Collins

 | May 13, 2015 | 12:30 PM EDT

Endo Pharmaceuticals could offer a short-term play.

bullishEndo estimates, target boosted at Deutsche

Apr 13, 2015 | 8:15 AM EDT

Shares of ENDP now seen reaching $96, according to Deutsche Bank. Estimates also upped, as Xiaflex should drive growth. Buy rating. 

By

Jim Cramer

 | Mar 16, 2015 | 9:30 AM EDT

Take a look at some more of its recent moves.

CME Group (CME) raised it quarterly payout by 20%, from 50-cents to 60-cents. Dunkin' Bran...
Johnson & Johnson (JNJ) saw a $15,762,000 sale (151,000 shares) at about a $104.10 ave...
Today's Wall Street Journal noted these purchases in stocks I've written up positively in ...
My Stock Market Super Bowl Indicator · The heavier the Super Bowl advertis...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.